​
 

Viscient is committed to utilizing its proprietary
3D tissue and multi-omics technologies to discover and develop drugs across a range of therapeutic areas. We understand the importance of developing meaningful collaborations and are actively seeking mutually beneficial partnerships that further our goals of developing drugs for
diseases with significant unmet medical need.

 

Please contact us to discuss further.